Page 6 - இதழ் ஆஃப் தி முதுமறதி சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

iPolitics By Terrence Young. Published on Jun 22, 2021 5:18pm The pharmaceutical industry is the only major industry that never guarantees its products will work, and never gives anyone their money back if they don’t work. (Pexels photo) In a stunning upset for a Big Pharma company, on June 7, the U.S. Food and Drug Administration fast-tracked approval of an experimental drug to treat cognitive decline in Alzheimer’s patients called aducanumab (brand name Aduhelm). The news was disturbing to many American and Canadian doctors who treat Alzheimer’s patients, because the the U.S. Food and Drug Administration (FDA) approved Aduhelm, made by Biogen, based on suspect and contradictory research, and went against the advice of its own expert advisers.

United statesMichael vounatsosDrug administrationHealth canadaJournal of the alzheimer associationBig pharmaFederal foodCosmetic actNorth americaஒன்றுபட்டது மாநிலங்களில்ஆரோக்கியம் கனடாஇதழ் ஆஃப் தி முதுமறதி சங்கம்பெரியது பார்மாகூட்டாட்சியின் உணவுஒப்பனை நாடகம்வடக்கு அமெரிக்கா